CORCEPT THERAPEUTICS INC - Common Stock (CORT)
CUSIP: 218352102
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 105,274,735
- Total 13F shares
- 81,489,147
- Share change
- -5,875,634
- Total reported value
- $1,813,024,077
- Put/Call ratio
- 71%
- Price per share
- $22.25
- Number of holders
- 224
- Value change
- -$128,901,748
- Number of buys
- 89
- Number of sells
- 128
Quarterly Holders Quick Answers
What is CUSIP 218352102?
CUSIP 218352102 identifies CORT - CORCEPT THERAPEUTICS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 218352102:
Top shareholders of CORT - CORCEPT THERAPEUTICS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
15%
|
16,128,815
|
$349,350,134 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.9%
|
10,434,744
|
$226,016,556 | — | 31 Mar 2023 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
8%
|
8,370,017
|
$181,295,000 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
6.4%
|
6,788,069
|
$147,030,000 | — | 31 Mar 2023 | |
| Parallel Advisors, LLC |
13F
|
Company |
3.5%
|
3,724,573
|
$80,674,251 | — | 31 Mar 2023 | |
| Novo Holdings A/S |
13F
|
Company |
3.2%
|
3,377,768
|
$73,162,455 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
3,290,905
|
$71,281,002 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.6%
|
2,760,296
|
$59,788,011 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.3%
|
2,435,152
|
$52,745,000 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2%
|
2,154,007
|
$46,655,756 | — | 31 Mar 2023 | |
| Boston Trust Walden Corp |
13F
|
Company |
1.8%
|
1,919,179
|
$41,569,417 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
1,793,927
|
$38,856,474 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.3%
|
1,351,594
|
$29,275,526 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
1%
|
1,093,213
|
$23,678,994 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.88%
|
927,911
|
$20,098,552 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.85%
|
889,963
|
$19,276,599 | — | 31 Mar 2023 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.76%
|
795,076
|
$17,221,346 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.74%
|
784,199
|
$16,985,751 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.74%
|
776,677
|
$16,822,824 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.65%
|
689,032
|
$14,924,433 | — | 31 Mar 2023 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.65%
|
681,078
|
$14,765,814 | — | 31 Mar 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.56%
|
586,259
|
$12,698,370 | — | 31 Mar 2023 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.49%
|
519,556
|
$11,253,583 | — | 31 Mar 2023 | |
| AJ WEALTH STRATEGIES, LLC |
13F
|
Company |
0.48%
|
509,934
|
$11,045,170 | — | 31 Mar 2023 | |
| ARISTEIA CAPITAL, L.L.C. |
13F
|
Company |
0.48%
|
501,558
|
$10,863,746 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
403,431
|
$8,738,316 | — | 31 Mar 2023 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.35%
|
366,220
|
$7,932,000 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.34%
|
362,778
|
$7,857,772 | — | 31 Mar 2023 | |
| S&T BANK/PA |
13F
|
Company |
0.33%
|
350,924
|
$7,601,000 | — | 31 Mar 2023 | |
| Shay Capital LLC |
13F
|
Company |
0.33%
|
350,000
|
$7,581,000 | — | 31 Mar 2023 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.33%
|
348,810
|
$7,555,225 | — | 31 Mar 2023 | |
| LMR Partners LLP |
13F
|
Company |
0.33%
|
343,254
|
$7,434,882 | — | 31 Mar 2023 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.32%
|
339,000
|
$7,342,740 | — | 31 Mar 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.32%
|
333,729
|
$7,228,570 | — | 31 Mar 2023 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.29%
|
306,254
|
$6,633,462 | — | 31 Mar 2023 | |
| FAS Wealth Partners, Inc. |
13F
|
Company |
0.29%
|
305,026
|
$6,606,864 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.28%
|
290,592
|
$6,294,000 | — | 31 Mar 2023 | |
| BURNEY CO/ |
13F
|
Company |
0.27%
|
286,869
|
$6,213,593 | — | 31 Mar 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.27%
|
279,361
|
$6,050,958 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
247,052
|
$5,351,000 | — | 31 Mar 2023 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.22%
|
227,546
|
$4,928,646 | — | 31 Mar 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.21%
|
223,171
|
$4,833,884 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.21%
|
221,012
|
$4,787,120 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.2%
|
210,784
|
$4,566,000 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.2%
|
209,165
|
$4,530,514 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.18%
|
191,424
|
$4,146,244 | — | 31 Mar 2023 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.17%
|
184,096
|
$3,988,000 | — | 31 Mar 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.17%
|
181,330
|
$3,927,608 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.17%
|
178,059
|
$3,856,758 | — | 31 Mar 2023 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.16%
|
168,505
|
$3,649,818 | — | 31 Mar 2023 |
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2023
As of 30 Jun 2023,
CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by
224 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,489,147 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, Parallel Advisors, LLC, Novo Holdings A/S, STATE STREET CORP, FEDERATED HERMES, INC., DIMENSIONAL FUND ADVISORS LP, and Boston Trust Walden Corp.
This page lists
224
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
231
Q2 2023 holders
224
Holder diff
-7
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.